Atlas Trials

Study of Mixed Vaccination Schedules With a 21-valent Pneumococcal Conjugate Vaccine and a 20-valent Pneumococcal Conjugate Vaccine in Healthy Infants From Approximately 2 Months of Age

Clinical trial NCT06824181 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT06824181
Sponsor
Sanofi
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 3
Study type
INTERVENTIONAL
Pneumococcal Immunization
Start date
2025-02-27
Primary completion
2027-09-10
Enrollment
580

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.